LUMOSA THERAPEUTICS CO LTD(TW:6535)
NT$80.80+7.30 (+9.93%)
TW:6535
LUMOSA THERAPEUTICS CO LTD financials statements
NT$80.80
At close:+7.30 (+9.93%)
LUMOSA THERAPEUTICS CO LTD (6535) Income Statement
LUMOSA THERAPEUTICS CO LTD Income Statement
Last quarter (Q2 2026), LUMOSA THERAPEUTICS CO LTD's total revenue was NT$5.13M, an increase of 135.28% from the same quarter last year. In Q2, LUMOSA THERAPEUTICS CO LTD's net income was NT$-161.93M. See LUMOSA THERAPEUTICS CO LTD’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 35.83M | NT$ 39.15M | NT$ 56.92M | NT$ 26.64M | NT$ 17.36M | |
| NT$ 21.87M | NT$ 17.71M | NT$ 41.48M | NT$ 14.56M | NT$ 9.89M | |
| NT$ 355.36M | NT$ 374.66M | NT$ 417.26M | NT$ 320.48M | NT$ 440.17M | |
| Depreciation and Amortization | NT$ 11.26M | NT$ 8.41M | NT$ 23.36M | NT$ 22.16M | NT$ 32.10M |
| NT$ -322.23M | NT$ -428.24M | NT$ -226.68M | NT$ -482.13M | NT$ 128.31M | |
| NT$ -333.49M | NT$ -356.94M | NT$ -375.63M | NT$ -305.92M | NT$ -430.28M | |
| NT$ -13.13M | NT$ -79.89M | NT$ 125.54M | NT$ -198.53M | NT$ 526.22M | |
| NT$ -346.62M | NT$ -436.84M | NT$ -250.09M | NT$ -504.44M | NT$ 95.95M | |
| NT$ -346.62M | NT$ -424.78M | NT$ -238.04M | NT$ -494.66M | NT$ 95.95M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -2.05 | NT$ -2.61 | NT$ -1.47 | NT$ -3.04 | NT$ 0.64 |
| Diluted EPS | NT$ -2.05 | NT$ -2.61 | NT$ -1.47 | NT$ -3.04 | NT$ 0.64 |
| Weighted Average Shares Outstanding | 166.12M | 163.49M | 161.93M | 162.77M | 150.65M |
| Weighted Average Shares Outstanding (Diluted) | 166.12M | 163.49M | 161.93M | 162.77M | 150.92M |
Currency in TWD
